Combined Treatment With Hyperbaric Oxygen Therapy and Endovascular Therapy for Patients With Chronic Limb-Threatening

Yusuke Sato1, Kazushi Urasawa1, Tetsuji Morishita2

  • 1Cardiovascular Center, Tokeidai Memorial Hospital Sapporo Japan.

Circulation Reports
|December 24, 2021
PubMed

Insights

Hyperbaric oxygen therapy (HBOT) combined with endovascular therapy (EVT) may improve wound healing in chronic limb-threatening ischemia (CLTI) patients. This study investigates HBOT

Area of Science:

  • Vascular Surgery
  • Hyperbaric Medicine
  • Regenerative Medicine

Background:

  • Chronic limb-threatening ischemia (CLTI) poses a significant risk of lower-limb amputation.
  • Hyperbaric oxygen therapy (HBOT) is an adjunctive treatment option for CLTI.
  • Current guidelines recommend HBOT alongside, not instead of, revascularization for CLTI.

Purpose of the Study:

  • To evaluate the efficacy of HBOT when added to successful endovascular therapy (EVT) in CLTI patients.
  • To assess the impact of HBOT on wound healing and limb salvage in CLTI.
  • To determine if HBOT improves outcomes after EVT for CLTI.

Main Methods:

  • A multicenter prospective randomized open blinded-endpoint trial (HOTFOOT study).
  • 140 CLTI patients undergoing successful EVT will be randomized 1:1 to EVT+HBOT or EVT alone.
  • Participants will receive 30 HBOT sessions over a 6-month follow-up period.

Main Results:

  • Primary outcome: time to complete wound healing.
  • Secondary outcomes: proportion of complete wound healing, freedom from major amputation, amputation-free survival, and target lesion reintervention.
  • Data collection and analysis will occur over a 6-month follow-up period.

Conclusions:

  • The study aims to determine if combining HBOT with EVT enhances lower-limb outcomes in CLTI patients.
  • Findings will inform clinical practice regarding the use of HBOT as an adjunct therapy for CLTI.
  • This research is expected to provide evidence on the role of HBOT in improving wound healing and preventing amputation in CLTI.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
341
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
48
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
273
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
238
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
52
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
45